AMRI, HarkerBIO collaborate

Friday, June 5, 2015

Albany Molecular Research (AMRI), a CRO based in Albany, N.Y., has signed a collaborative agreement with Buffalo, N.Y.-based biotechnology company HarkerBIO to co-market their structure-based drug discovery services to global pharmaceutical and biotechnology clients. AMRI gains access to HarkerBIO’s differentiated high-resolution, structure-determination experience and capabilities. HarkerBIO’s customers will be able to access and benefit from AMRI’s global capabilities, including their integrated drug discovery platforms and solutions.

[Read More]